Bavarian Nordic and Janssen to develop vaccines against HIV-1 and hepatitis B

Danish biotechnology company Bavarian Nordic has entered an additional worldwide exclusive licence and collaboration agreement with Janssen Pharmaceuticals for the development of vaccine regimens against HIV-1 and hepatitis B.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news